Cargando…
Discovery of a Novel MyD88 Inhibitor M20 and Its Protection Against Sepsis-Mediated Acute Lung Injury
Myeloid differentiation factor 88 (MyD88) is a hub protein in the Toll-like receptor signaling pathway, which acts as a master switch for numerous inflammatory diseases, including acute lung injury (ALI). Although this protein is considered as a crucial therapeutic target, there are currently no cli...
Autores principales: | Song, Jiali, Chen, Daoxing, Pan, Yingqiao, Shi, Xueqin, Liu, Qian, Lu, Xiaoyao, Xu, Ximing, Chen, Gaozhi, Cai, Yuepiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666603/ https://www.ncbi.nlm.nih.gov/pubmed/34912226 http://dx.doi.org/10.3389/fphar.2021.775117 |
Ejemplares similares
-
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
por: Luo, Wu, et al.
Publicado: (2022) -
LXR agonist inhibits inflammation through regulating MyD88 mRNA alternative splicing
por: Li, Ni, et al.
Publicado: (2022) -
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity
por: Saikh, Kamal U.
Publicado: (2021) -
Antibiotics Attenuate Methamphetamine-Induced Hepatotoxicity by Regulating Oxidative Stress and TLR4/MyD88/Traf6 Axis
por: Chen, Li-Jian, et al.
Publicado: (2021) -
Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
por: Chen, Junbin, et al.
Publicado: (2020)